Overall, our study demonstrates the multiple potentials of DDR1 in the immunotherapy of gastric cancer, including immune infiltration and tumor invasion, and also expands the direction of DDR1 signaling mechanism research. This evidence concerns the gene DDR1 and gastric cancer.